Effects of berberine on cholinesterases and monoamine oxidase activities, and antioxidant status in the brain of streptozotocin (STZ)-induced diabetic rats
Authors:
- 16 March 2021
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Basic and Clinical Physiology and Pharmacology
- Vol. 33 (4) , 389-397
Abstract
Objectives: Several studies had been conducted to examine the link between diabetes and diabetes encephalopathy. This study was conducted to examine the potency of berberine (BER) on the restoration of impaired neurochemicals in the brain of streptozotocin (STZ)-induced diabetic Wistar rats. Methods: Fifty-six (56) adult rats weighing between 200 and 230 g were randomly divided into seven groups (n=8) as follows; Group I is normal control; Groups II and III were normal rats treated with 50 and 100 mg/kg respectively; Group IV–VII were STZ-induced rats, but Groups V–VII were treated with acarbose (25 mg/kg), 50 and 100 mg/kg of BER, respectively. Results: The result of the study showed that untreated STZ-induced diabetic rats have increased acetylcholinesterase (AChE), butyrylcholinesterase (BChE), monoamine oxidase (MAO) activities, and malonylaldehyde (MDA) level, with concomitant decrease of superoxide dismutase (SOD), glutathione peroxidase (GPx) activities, and glutathione (GSH) level. However, daily treatment with 50 and 100 mg/kg BER and ACA significantly reversed these effects. Conclusions: The findings of this study clearly indicated that BER possesses neuro-protective and antioxidative potentials and normalize neurochemical impairment distort by diabetes.Keywords
This publication has 70 references indexed in Scilit:
- Medicinal plants for diabetes associated neurodegenerative diseases: A systematic review of preclinical studiesPhytotherapy Research, 2020
- Cognitive impairment and dementia: a new emerging complication of type 2 diabetes—The diabetologist’s perspectiveActa Diabetologica, 2017
- The Impact of Diabetes on Cerebral Structure and FunctionPsychosomatic Medicine, 2015
- Insulin Regulates Brain Function, but How Does It Get There?Diabetes, 2014
- Diabetes and the brain: issues and unmet needsNeurological Sciences, 2014
- Diabetes and neurodegeneration in the brain2014
- Sugar for the brain: the role of glucose in physiological and pathological brain functionTrends in Neurosciences, 2013
- Neurodegeneration in Diabetes Mellitus2012
- Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalencePopulation Health Metrics, 2010
- Cerebrovascular Pathology and Dementia in Autopsied Honolulu‐Asia Aging Study ParticipantsAnnals of the New York Academy of Sciences, 2002